In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

Member Benefit

This content is only available year-round to ESC Professional Members, Fellows of the ESC, and Young Combined Members

The microvascular obstruction and intramyocardial haemorrhage: impact of different reperfusion strategies in primary myocardial infarction

Session Poster Session 1

Speaker Evgeny Vyshlov

Event : ESC Congress 2019

  • Topic : imaging
  • Sub-topic : Imaging of Acute Coronary Syndromes
  • Session type : Poster Session

Authors : E Vyshlov (Tomsk,RU), YA Alekseeva (Tomsk,RU), V Usov (Tomsk,RU), V Ryabov (Tomsk,RU)

Authors:
E. Vyshlov1 , Y.A. Alekseeva1 , V. Usov1 , V. Ryabov1 , 1Cardiology Research Institute, Tomsk National Research Medical Centre, Russian Academy of Sciences - Tomsk - Russian Federation ,

Topic(s):
Imaging: Acute Coronary Syndromes

Citation:
European Heart Journal ( 2019 ) 40 ( Supplement ), 221

Background: The coronary reperfusion in patients with ST-elevated myocardial infarction (STEMI) is often complicated by reperfusion-ischemic myocardial injury: microvascular obstruction (MVO) and intramyocardial haemorrhage (IMH). Contrast-enhanced cardiac magnetic resonance imaging (MRI) is the best diagnostic method, which allows to assess these phenomena. It is known that in patients with STEMI and primary percutaneous coronary intervention (PCI), the prevalence rates of MVO and IMH are 50–60% and 40–50%, respectively. There is not enough knowledge about the prevalence of these phenomena in patients with pharmaco-invasive strategy.

Purpose: The aim of the study was to evaluate the prevalence of MVO and IMH in patients with primary STEMI and different reperfusion strategies.

Materials and methods: This observational cohort study included 47 patients with primary STEMI within the first 12 hours after the onset of disease. Exclusion criteria: pulmonary edema, cardiogenic shock, creatinine clearance <30 mL/min or dialysis, severe comorbidity, acute psychotic disorders, and inability to undergo or contra-indications for MRI. These patients were divided into 2 groups. Patients of group 1 (n=30) were treated with a pharmaco-invasive strategy. Fibrinolysis was performed in all patients in the pre-hospital setting. Patients of group 2 (n=17) were treated by primary PCI. MRI was performed at day 2 post-STEMI in all patients. Late gadolinium enhancement and T2-weighted IMH imaging for microvascular obstruction and IMH were used.

Results: Patients with primary PCI more often had MVO: 70.5% (n=12) vs. 40% (n=12) in the pharmaco-invasive group (p=0.05). The occurrence of IMH between the groups did not significantly differ: 40% (n=12) in group 1 vs. 64.7% (n=11) in group 2, respectively. The presence of combination of MVO with IMH was observed significantly more often in group of primary PCI: 47% (n=8) vs. 20% (n=6) (p=0.03). The left ventricular ejection fraction was significantly lower in patients with combination of IMH and MVO compared to those without it: 55% (34–66) vs. 62.5% (53–72) (p=0.01).

Conclusion: MVO and IMH were common findings in patients with primary STEMI and different reperfusion strategies and were present in 40% to 70% of patients. The MVO and combination of MVO with IMH occurred significantly more often in the group of primary PCI. The prevalence rates of IMH in patients with different reperfusion strategies did not significantly differ.

ClinicalTrials.gov, identification number is NCT03677466.

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now
logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are